BTK and Alzheimer disease: Finally we used the recently created Brain Myeloid Landscape platform (Friedman et al. 2018) to assess BTK transcript levels in two separate gene expression datasets from AD patient bulk brain tissues: GSE15222 in temporal cortex measured by microarray (Webster et al. 2009) and GSE95587 in fusiform gyrus measured by RNA-sequencing (Friedman et al. 2018) (Fig. 5g).